← Evidence map

ArticleHepatology (Baltimore, Md.)2014

Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response.

Kian Bichoupan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2014
2015
2016
2017
2018
2019
2020
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25065814